Introduction: Positron emission tomography combined with computed axial tomography (PET/CT) is used for staging non small cell lung cancer (NSCLC). This study aims to describe PET/CT findings of unsuspected extrathoracic metastasis when used in mediastinal evaluation of patients with apparently resectable NSCLC.

Patients And Method: Prospective and concurrent study including all NSCLC patients between June 2004 and November 2006 who underwent PET/CT after considering them as candidates for surgery, with resectable disease after bronchoscopy, thorax and abdominal CT, brain CT and bone gammagraphy evaluation, if metastasis at these locations were suspected. Metastasis were confirmed histopathologically or assumed when they had a compatible evolution.

Results: A total of 91 patients with NSCLC underwent PET/CT. In 24 of them (26%) at least one suspicious extrathoracic uptake was seen. In 7 patients (7.7%) those uptakes were NSCLC extrathoracic metastasis hidden from conventional staging. In 3 of these cases (13.1%) extrathoracic uptakes corresponded to metacrhonous tumours or pre-malignant conditions. Benign lesions were found in 12 patients (13.1%), and in 2 cases (2.2%) the uptake origins were undetermined.

Conclusions: PET/CT is a complementary diagnosis method for assessing hidden metastases which could modify the therapeutical approach in patients otherwise suitable for surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arbres.2010.02.003DOI Listing

Publication Analysis

Top Keywords

extrathoracic metastasis
12
positron emission
8
emission tomography
8
assessing hidden
8
small cell
8
cell lung
8
underwent pet/ct
8
patients
6
extrathoracic
5
metastasis
5

Similar Publications

Introduction: Endobronchial metastases (EBMs) are rare, with primary tumours predominantly of breast, renal, and colorectal origin. Bronchoscopy is the diagnostic gold standard, with histological confirmation through immunohistochemical study.

Cases: We presented three cases of EBMs, one secondary to colorectal cancer and two associated with renal tumours.

View Article and Find Full Text PDF

Basement membranes in lung metastasis growth and progression.

Matrix Biol

February 2025

Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Spain. Electronic address:

The lung is a highly vascularized tissue that often harbors metastases from various extrathoracic malignancies. Lung parenchyma consists of a complex network of alveolar epithelial cells and microvessels, structured within an architecture defined by basement membranes. Consequently, understanding the role of the extracellular matrix (ECM) in the growth of lung metastases is essential to uncover the biology of this pathology and developing targeted therapies.

View Article and Find Full Text PDF
Article Synopsis
  • * Results show that adding PRT significantly improves overall survival in patients treated with chemotherapy, though the benefit is less pronounced in the immunotherapy era and not observed in patients with multiple distant metastases.
  • * A predictive nomogram was developed to help identify patients who would benefit most from PRT, indicating that those receiving systemic preoperative therapy had better outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - Thymomas are rare and malignant tumors of the thymus gland, with isolated metastasis to the liver being extremely uncommon.
  • - An 89-year-old man presented with urinary retention, leading to imaging that revealed a mass near the aortopulmonary window and a lesion in the liver, ultimately diagnosed as metastatic type B2 thymoma.
  • - This case highlights the challenges in identifying metastatic thymoma; any mediastinal mass should prompt evaluation for possible metastasis, especially in older patients.
View Article and Find Full Text PDF

Objective: For patients with non-small cell lung cancer, microscopic residual disease (R1) is sometimes inevitable after sleeve lobectomy. However, the necessity for extensive pneumonectomy after sleeve lobectomy with R1 status remains unclear, especially when the patient cannot tolerate surgery.

Methods: We retrospectively collected the clinical data of 366 patients who underwent sleeve lobectomy for microscopic residual disease (SLobR1) or pneumonectomy between 2015 and 2019 at Shanghai Chest Hospital, China.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!